Pranlukast is a selective cysteinyl leukotriene receptor-1 antagonist, an anti-inflammatory medication primarily used to treat asthma by inhibiting bronchoconstriction and airway inflammation. This category… Read more









Pranlukast is a selective cysteinyl leukotriene receptor-1 antagonist, an anti-inflammatory medication primarily used to treat asthma by inhibiting bronchoconstriction and airway inflammation. This category features high-quality pharmaceutical reference standards essential for the critical analysis of the drug substance. These materials include pharmacopeial and non-pharmacopeial impurities, specific human metabolites, and stable isotope-labelled compounds such as deuterated analogues. Laboratories rely on these analytical standards to perform rigorous impurity profiling, conduct stability studies, and ensure accurate method validation for quality control workflows. By utilizing these precise reference materials, researchers can effectively identify, quantify, and monitor degradation products and metabolic pathways during pharmaceutical development and routine regulatory compliance testing.